Table 2

Primers used for amplification of the splice variants of TRAIL and TRAIL receptors

Product namePrimerSequence 5’→3’LocationProduct length (bp)
TRAIL-αTRAIL-fwd1TTCTACAGTTCAAGAAAAGCExons 3–4 joint145
TRAIL-rev1GCCCAGAGCCTTTTCATTCTExons 4–5 joint
TRAIL-βTRAIL-fwd2AGCTCGTTAGAAAGAAAAGCExons 2–4 joint195
TRAIL-rev2CTCAGGAATGAATGCCCACTExon
TRAIL-γTRAIL-fwd3ACGAGCTGAAGCAGAAAAGCExons 1–4 joint145
TRAIL-rev1GCCCAGAGCCTTTTCATTCTExons 4–5 joint
TRAILR-1TRAILR1-fwdACCAGGAACACAGCATGTCAExon132
TRAILR1-revGTCACTCCAGGGCGTACAATExon
TRAILR-2 isoform 1TRAILR2-fwdCAGTGCGAAGAAGGCACCTTExon 4145
TRAILR2-rev1CCCCACTGTGCTTTGTACCT87 bp insertion in exon 5
TRAILR-2 isoform 2TRAILR2-fwdCAGTGCGAAGAAGGCACCTTExon 4157
TRAILR2-rev2TGATGCCTGATTCTTTGTGGExon 5
TRAILR-3TRAILR3-fwdTGCACAGAGGGTGTGGATTAExon108
TRAILR3-revGGTCATGGTGCAGGAACTTTExon
TRAILR-4 αTRAILR4-fwd1CAATTTGCCTTCTTGCCTGCExon 3164
TRAILR4-revCTCTGGGACACCCTGTTCTAExons 4–5 joint
TRAILR-4 βTRAILR4-fwd2GGAGTGTCCAGCAGGTCAAAExons 2–4 joint137
TRAILR4-revCTCTGGGACACCCTGTTCTAExons 4–5 joint
GADPHGADPH-fwdGAAGATGGTGATGGGATTTCExon225
GADPH-revGAAGGTGAAGGTCGGAGTExon
  • TRAIL, Tumour necrosis factor-Related Apoptosis Inducing Ligand.